Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 7, 1998, Pages 1035-1045

  Lijnen, H Roger ^a   Van Hoef, Berthe ^a   Lupu, Florea ^b   Moons, Lieve ^c   Carmeliet, Peter ^c   Collen, Désiré ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Fibrinolysis; Gelatinase; Neointima; Restenosis; Transgenic mice

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CONTROLLED STUDY; FIBRINOLYSIS; GENE ACTIVATION; HUMAN TISSUE; INTIMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

EID: 0031903487     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.7.1035     Document Type: Article

References (15)

1. Schwartz SM, Reidy MA, O'Brien ER. Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb Haemost. 1995;74:541-551.
2. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 1991;17:77B-88B.
3. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation. 1992;86(suppl III): III-47-III-52.
4. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia: a review. J Vasc Surg. 1991;13:885-891.
5. Reidy MA, Jackson D, Lindner V. Neointimal proliferation: control of vascular smooth muscle cell growth. Vasc Med Rev. 1992;3:156-167.
6. Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
7. Jackson CL, Reidy MA. The role of plasminogen activation in smooth muscle cell migration after arterial injury. Ann NY Acad Sci. 1992;667:141-150.
8. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996;78:405-414.
9. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
10. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
11. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991;78:3114-3124.
12. Vassalli JD. The urokinase receptor. Fibrinolysis. 1994;8(suppl 1):172-181.
13. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C. The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis. 1994;8(suppl 1): 189-203.
14. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
15. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455-463.